 |
Click here for
NJ Preventive Cardiology practice brochure
|
Mentoring Program |
|
The Million Hearts
Initiative

For Physicians:
Practical Tips for
Clinicians

For Communities:
Heart2Heart Talk

For Employers and Employees:
You and Health Reform

|
|
|
 |
|  | 
If you are one of the more than 40 million Americans at high risk as shown above, you are eligible of optimal evidence-based heart attack and stroke prevention.
Does one have to have symptoms of the disease to seek treatment? The answer is NO. Ideally, preventive treatment should start before symptoms appear.
If you have any one of these diagnosis, your risk for heart attack, stroke or cardiac death in the next 10 years is greater than 1 in 5. If the risk for need for stent, heart bypass surgery, angina, TIA, etc. are included, the risk is even higher.
Previous heart attack, stent, heart bypass and angina
Previous stroke, TIA, claudication, carotid or leg artery bypass or stent
Diabetes
Framingham risk score greater than 20%
Reynolds score over 20%
Framingham risk score between 6% to 20%, plus high coronary calcium score by high speed cardiac CT, or high hs-CRP, or abnormal carotid IMT, or reduced ABI.

Not all risk factors are created equal and not all patients require the same intensity of treatment - some patients may not need drug therapy in addition to healthier diet and positive lifestyle changes. While some risk factors are not modifiable, optimal treatment of modifiable risk factors can negate their adverse impact on cardiovascular health.
Our approach is personalized and our evidence-based treatment is customized to each individual patient to obtain the maximum benefits with the least possible side effects. We closely monitor response to therapy to achieve the best possible clinical outcomes.
|  |
|
Emil M. deGoma, MD, FACC
Medical Director,
UPenn Preventive
Cardiovascular Program
|
Health Premium Discount |
Lower your risk for heart attack and stroke
using evidence-based therapies and become
eligible for a substantial premium discount by
2014.
 |
|
 |
|
|
Health Reform 2010 |
Prevention and Wellness Summary Provisions
 |
|
 |
|
|
Relay Health |
Contact Office for Non-Urgent Matters
 |
|
 |
|
We Support
Million Hearts Initiative
497,470 Preventable CHD Deaths
Annually with
Evidence-based Medical Therapy
JAMA: 38% of Nonacute
Stents Called into Question
Optimal Medical Therapy Still Underused in
CHD
Legacy Effects
of Statin Therapy - Reduction in
All-Cause Mortality
SG2 Expert Talks About Resetting
Priorities in Cardiology
AHA: Get With The Guidelines - Not Much
Improvement
AIM-HIGH Trial -
Take Home
Message
|